{"nct_id":"NCT07081633","title":"Durvalumab and Tremelimumab With Lenvatinib as First-line Treatment in Patients With Unresectable Hepatocellular Carcinoma","status":"RECRUITING","status_verified_date":"2025-08","start_date":"2025-08-05","start_date_type":"ACTUAL","primary_completion_date":"2026-11-30","primary_completion_date_type":"ESTIMATED","completion_date":"2028-12-31","completion_date_type":"ESTIMATED","phases":["PHASE2"],"tickers":["AZN"]}